Making sense of telemedicine in the management of COPD
- PMID: 29848578
- DOI: 10.1183/13993003.00851-2018
Making sense of telemedicine in the management of COPD
Conflict of interest statement
Conflict of interest: J. Bourbeau reports grants from the Canadian Institute of Health Research (CIHR), Canadian Respiratory Research Network (CRRN) and the Research Institute of the MUHC and the FRQS; grants and personal fees (advisor and lectures) from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Grifols and Novartis, outside the submitted work.
Comment on
-
Efficacy and costs of telehealth for the management of COPD: the PROMETE II trial.Eur Respir J. 2018 May 30;51(5):1800354. doi: 10.1183/13993003.00354-2018. Print 2018 May. Eur Respir J. 2018. PMID: 29599185 Clinical Trial. No abstract available.